J. Alexandre

发表

Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations.

J. Ménard, P. Plouin, J. Duclos, 1981, British medical journal.

The meaning of dopamine beta-hydroxylase in essential hypertension.

M. Safar, G. London, C. Chevillard, 1975, Clinical science and molecular medicine.

Prognostic Value of Plasma Renin Activity in Renovascular Hypertension

L. Guize, P. Biron, J. Alexandre, 1967, Pathologie et biologie.

Study Design in Osteoporosis: A European Perspective

S. Durrleman, O. Chassany, E. Abadie, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension

M. Safar, A. Simon, C. Chevillard, 2004, European Journal of Clinical Pharmacology.

Dose Dependency of Captopril Effects in Severely Hypertensive Patients

J. Ménard, P. Corvol, J. Aldigier, 1981, Journal of cardiovascular pharmacology.

Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.

G. Chatellier, C. Funck-Brentano, J. Alexandre, 1986, British heart journal.

Mechanism of renin release following furosemide diuresis in rabbit.

J. Alexandre, N. Papanicolaou, C. Devaux, 1968, The American journal of physiology.

INFLUENCE OF β‐ADRENOCEPTOR BLOCKING AGENTS ON THE TURNOVER RATE OF CARDIAC AND SPLENIC NORADRENALINE IN RATS

C. Chevillard, J. Alexandre, 1980, British journal of pharmacology.

Relationship between renin and extracellular fluid volume in normotensive and hypertensive subjects.

A. Simon, J. Levenson, M. Safar, 1980, Nephron.

Mechanism of inhibition of renin release by clonidine in rats.

C. Chevillard, J. Alexandre, R. Pasquier, 1978, European journal of pharmacology.

[Determination of the plasma renin activity in 261 hypertensives].

C. Leroux-Robert, J. Alexandre, C. Devaux, 1966, La Presse medicale.

Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trial.

A. Fournier, G. Lambrey, M. Andréjak, 1979, Clinical nephrology.

(+)-Propranolol clearance, an estimation of hepatic blood flow in man.

A. Simon, J. Levenson, M. Safar, 1978, British journal of clinical pharmacology.

Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and dopamine-beta-hydroxylase activities.

A. Fournier, J. Alexandre, J. Hardin, 1976, Clinical science and molecular medicine. Supplement.

The meaning of dopamine p-hydroxylase in essential hypertension

G. London, C. Chevillard, Weiss, 2012 .

[Equilibration of the treatment of severe arterial hypertension. Significance of d-1 propranolol].

J. Ménard, P. Corvol, M. Meignan, 1975, La Nouvelle presse medicale.

RE; CPMP SWP comments on the FDA Guidance OI-I Photomfety Testing

J. Alexandre, M. Lumpkin, L. Miiller, 2000 .

In vitro effects on cardiac norepinephrine of angiotensin II and of two indirectly acting sympathomimetic amines (amphetamine and tyramine). A study of their combinations.

C. Chevillard, J. Alexandre, 1972, European journal of pharmacology.

Lack of antihypertensive effects of chronic administration of DL-propranolol in Grollman rats.

J. Ménard, C. Auzan, C. Chevillard, 1973, Archives internationales de pharmacodynamie et de therapie.

[Anticoagulant treatment with fluindione. Relation between the decrease of vitamin K-dependent factors and blood fluindione].

J. Fiessinger, M. Aiach, J. Alexandre, 1986, Therapie.

Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril.

M. Henry-Amar, F. Forette, M. Fouchard, 1987, Gerontology.

Uncertain Future of Trials in Osteoporosis

O. Johnell, J. Kanis, E. Abadie, 2002, Osteoporosis International.

VARIATIONS IN RENIN AND ITS SUBSTRATE AFTER BINEPHRECTOMY

J. Alexandre, C. Devaux, P. Meyer, 1968 .

Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine

P. Corvol, M. Thibonnier, E. Singlas, 2004, European Journal of Clinical Pharmacology.

Correlations between plasma renin, hematocrit and natriuresis.

J. Alexandre, P. Meyer, J. Ménard, 1966, Revue canadienne de biologie.

RENAL-VEIN RENIN IN RENOVASCULAR HYPERTENSION

J. Alexandre, C. Devaux, P. Meyer, 1966 .

Total Effective Compliance, Cardiac Output and Fluid Volumes in Essential Hypertension

A. Simon, J. Levenson, M. Safar, 1978, Circulation.

Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.

J. Ménard, C. Chevillard, H. Schmitt, 1970, European journal of pharmacology.

Relation of the centrally evoked pressor effect of angiotensin II to central noradrenaline in the rabbit.

C. Chevillard, J. Alexandre, R. Pasquier, 1979, European journal of pharmacology.

[Hypertensive episodes triggered by sulpiride].

P. Corvol, C. Bohuon, J. Vaysse, 1974, La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris.

[Alpha-methyl -para-tyrosine in the prolonged treatment of malignant pheochromocytoma and preoperative care of benign pheochromocytoma: preliminary study].

J. Desmonts, J. Vaysse, J. Alexandre, 1972, Journal d'urologie et de nephrologie.

How does angiotensin II increase cardiac dopamine‐β‐hydroxylation?

C. Chevillard, J. Alexandre, N. Duchene, 1975 .